133 related articles for article (PubMed ID: 22958153)
41. Role of Helicobacter pylori in gastric carcinoma.
Prabhu SR; Amrapurkar AD; Amrapurkar DN
Natl Med J India; 1995; 8(2):58-60. PubMed ID: 7735060
[TBL] [Abstract][Full Text] [Related]
42. Effects of Helicobacter pylori Infection on gastric mucin expression.
Kang HM; Kim N; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Lee HS; Jung HC; Song IS
J Clin Gastroenterol; 2008 Jan; 42(1):29-35. PubMed ID: 18097286
[TBL] [Abstract][Full Text] [Related]
43. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
[TBL] [Abstract][Full Text] [Related]
44. [Effect of Helicobacter pylori infection on the apoptotic and cell proliferative processes of the gastric mucosa].
Törgyekes E; Molnár B
Orv Hetil; 1999 Apr; 140(14):755-60. PubMed ID: 10224845
[TBL] [Abstract][Full Text] [Related]
45. [Helicobacter pylori and the progression of gastric cancer: a 10-year cohort study].
Ma JL; Zhang L; Pan KF; Liu WD; Feng GS; You WC
Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2758-61. PubMed ID: 16324316
[TBL] [Abstract][Full Text] [Related]
46. Helicobacter pylori infection and histological changes in siblings of young gastric cancer patients.
Nam JH; Choi IJ; Cho SJ; Kim CG; Lee JY; Nam SY; Park SR; Kook MC; Nam BH; Kim YW
J Gastroenterol Hepatol; 2011 Jul; 26(7):1157-63. PubMed ID: 21392104
[TBL] [Abstract][Full Text] [Related]
47. Helicobacter pylori, gastric cancer and gastric epithelial kinetics: a review.
Lynch DA; Axon AT
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S17-23. PubMed ID: 8574730
[TBL] [Abstract][Full Text] [Related]
48. The non-invasive diagnosis of precancerous changes of stomach mucosa.
Pasechnikov VD; Chukov SZ; Kotelevets SM; Mostovov AN; Polyakova MB; Mernova VP
Rocz Akad Med Bialymst; 2004; 49():66-71. PubMed ID: 15631316
[TBL] [Abstract][Full Text] [Related]
49. A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication.
Zhou L; Sung JJ; Lin S; Jin Z; Ding S; Huang X; Xia Z; Guo H; Liu J; Chao W
Chin Med J (Engl); 2003 Jan; 116(1):11-4. PubMed ID: 12667379
[TBL] [Abstract][Full Text] [Related]
50. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan.
Kamada T; Hata J; Sugiu K; Kusunoki H; Ito M; Tanaka S; Inoue K; Kawamura Y; Chayama K; Haruma K
Aliment Pharmacol Ther; 2005 May; 21(9):1121-6. PubMed ID: 15854174
[TBL] [Abstract][Full Text] [Related]
51. Atrophy, metaplasia and dysplasia: are they reversible?
Genta RM
Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S324-5. PubMed ID: 10077766
[TBL] [Abstract][Full Text] [Related]
52. Host factors contributing to the discovery of gastric cancer after successful eradication therapy of Helicobacter pylori: preliminary report.
Takata S; Ito M; Yoshihara M; Tanaka S; Imagawa S; Haruma K; Chayama K
J Gastroenterol Hepatol; 2007 Apr; 22(4):571-6. PubMed ID: 17376053
[TBL] [Abstract][Full Text] [Related]
53. Intracellular, intercellular, and stromal invasion of gastric mucosa, preneoplastic lesions, and cancer by Helicobacter pylori.
Necchi V; Candusso ME; Tava F; Luinetti O; Ventura U; Fiocca R; Ricci V; Solcia E
Gastroenterology; 2007 Mar; 132(3):1009-23. PubMed ID: 17383424
[TBL] [Abstract][Full Text] [Related]
54. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
[TBL] [Abstract][Full Text] [Related]
55. Higher gastric cycloxygenase-2 expression and precancerous change in Helicobacter pylori-infected relatives of gastric cancer patients.
Sheu BS; Yang HB; Sheu SM; Huang AH; Wu JJ
Clin Cancer Res; 2003 Nov; 9(14):5245-51. PubMed ID: 14614005
[TBL] [Abstract][Full Text] [Related]
56. Prevention of gastric cancer: a challenging but feasible task.
Fry LC; Mönkemüller K; Malfertheiner P
Acta Gastroenterol Latinoam; 2007 Jun; 37(2):110-7. PubMed ID: 17684942
[TBL] [Abstract][Full Text] [Related]
57. Gastric cancer--epidemiologic and clinical aspects.
Venerito M; Nardone G; Selgrad M; Rokkas T; Malfertheiner P
Helicobacter; 2014 Sep; 19 Suppl 1():32-7. PubMed ID: 25167943
[TBL] [Abstract][Full Text] [Related]
58. Molecular pathogenesis of gastric cancer.
Figueiredo C; Garcia-Gonzalez MA; Machado JC
Helicobacter; 2013 Sep; 18 Suppl 1():28-33. PubMed ID: 24011242
[TBL] [Abstract][Full Text] [Related]
59. The interplay between
Chen CC; Liou JM; Lee YC; Hong TC; El-Omar EM; Wu MS
Gut Microbes; 2021; 13(1):1-22. PubMed ID: 33938378
[TBL] [Abstract][Full Text] [Related]
60. [Gastric cancer screening in Japan, now and tomorrow].
Nakajima S
Nihon Rinsho; 2012 Oct; 70(10):1686-93. PubMed ID: 23198546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
